It's a weekly injection that helps you feel satisfied with less food, so you're not constantly fighting through every meal
Contact your GP, specialist, or clinical trial team promptly if you experience: A spreading rash , hives (urticaria), or widespread skin redness that develops after starting treatment Swelling of the face, lips, tongue, or throat , which may indicate angioedema a potentially serious allergic reaction requiring urgent assessment Difficulty breathing or swallowing alongside skin changes call 999 immediately , as this could indicate anaphylaxis Signs of infection at an injection site , including increasing warmth, pus, significant swelling, or fever Persistent or worsening skin symptoms that do not improve with basic self-care measures after one to two weeks Unexplained bruising or bleeding beyond what would be expected from a subcutaneous injection If you are unsure whether your symptoms require urgent attention, NHS 111 can provide guidance
Not suitable for children under 15, pregnant or lactating women without medical advice
cystathionine gamma lyase, NADPH
Common uses Weight loss Metabolic health Appetite control Tirzepatide Medical Weight Loss Available Dual GIP/GLP-1 agonist often more potent than semaglutide for appropriate candidates
173 Its research findings were recently presented orally at the 83rd Scientific Sessions of the American Diabetes Association and published in the New England Journal of Medicine